Our Board

Board_john stanhope.jpg

Chairman - Mr John Stanhope AM

B Com, FCPA, FCA, FAICD, FAIM, FAHRI

John Stanhope’s career at Telstra Corporation spanned 45 years, and his last position before retirement was that of Chief Financial Officer and Group Managing Director (2003-2011), as well as executive director of the Telstra Board (2009-2011).

John’s experience has covered many areas including finance, treasury, taxation, risk management and assurance, investor relations, corporate security and investigations, directorships on various boards of Telstra Corporation’s national and international subsidiary companies, and membership of industry and government committees.

He is currently Chairman of Australia Post, a Director of AGL Energy Limited (Chair of Audit & Compliance Committee), the Chancellor of Deakin University, Chairman of the Port of Melbourne, Chairman of the Melbourne International Jazz Festival, Chair of the Australian Business Reporting Leaders Forum (BRLF) and Chairman of the Advisory council G100.  John is also a Fellow of a number of professional societies including the Australian Society of Certified Practising Accountants, the Australian Institute of Company Directors, and the Australian Institute of Management.

In June 2016, John was made a member (AM) in the General Division of the Order of Australia recognising his “significant service to the financial and national communications sectors through a range of leadership roles”.

 

Treasurer - Mr Brian Jamieson

FCA 

Brian Jamieson has over 30 years of experience in providing advice and audit services to a diverse range of public and large private companies.  He was Chief Executive of Minter Ellison Melbourne from 2002 to 2005.  Prior to joining Minter Ellison he was Chief Executive Officer at KPMG from 1998 to 2000, Managing Partner of KPMG Melbourne and Southern Regions from 1993 to 1998, and Chairman of KPMG Melbourne from 2001 to 2002.  He was also a KPMG Board member in Australia, and a member of the USA Management Committee.

Brian is Chairman of Mesoblast Limited and Chairman of Sigma Pharmaceuticals Limited.  He is a non-executive Director of Tatts Group Limited. He is an advisor to Steritech Pty Ltd.    Brian is a Fellow of the Institute of Chartered Accountants in Australia and a Fellow of The Australian Institute of Company Directors.

Deputy Chairman - Mr John Bryson

BEng (Mech), MBA (Melb), Visiting Fellow MIT, MAICD 

John Bryson has over 30 years’ experience in the finance industry. He was an Equity Owner/Director of JB Were and had various senior executive roles including Group General Manager, Group Retail Manager and Director Corporate Finance. Since 2003 he has been an active Board member of listed and unlisted companies, CEO of a large charitable foundation and undertaken a number of consulting roles.
 
John is also a Non-Executive Director of First Samuel Limited and of the Bionics Institute’s subsidiary Bionic Enterprises.  John was previously Non-Executive Director of Praemium Ltd and Choisuel Limited.

Board_McCluskey.jpg 

Professor James McCluskey 

BMedSci, MBBS, MD, FRACP, FRCPA, FAA, FAHMS 

Professor James McCluskey is the Deputy Vice-Chancellor (Research) at The University of Melbourne.

Professor McCluskey trained in Perth as a physician and pathologist. He has spent significant periods at the National Institutes of Health (USA), Monash University, Flinders University and the Australian Red Cross Blood Service. 

He is well known for his research in basic and clinical immunology and is recognised for his leadership in the field of immunogenetics. Professor McCluskey has published more than 300 scientific articles.  He has received the Rose Payne Medal from the American Society for Histocompatibility and Immunogenetics; the Ceppellini Award from the European Foundation for Immunogenetics; the GSK Award for Medical Research Excellence; an Australian Museum Eureka Award for Science; and the Victoria Prize for Life Sciences. 

He is a Fellow of the Australian Academy of Science; the Royal Australian College of Physicians; Royal College of Pathologists Australasia; and the Australian Academy of Health and Medical Sciences. 

He is a director of the Walter and Eliza Hall Institute of Medical Research; Victorian Comprehensive Cancer Centre; Nossal Institute Ltd; UoM Commercial; and Friends of ASHA for Indian Slums. He has worked for the Australian Red Cross Blood Service Service in transplantation matching and immunogenetics for more than 25 years. He led the development of the Peter Doherty Institute for Infection & Immunity and recently led the development of the Atantic Fellows for Social Equity program in partnership with the Commonwealth Government, Queensland University of Technology, University of Auckland, Jawun, Brotherhood of St Laurence and Business Council of Australia. The program is funded by a philanthropic gift of USD$50M from The Atlantic Philanthropies. 

Phil_Binns_edit1.jpg





Mr Philip Binns 

BApp Sc, PGDip Bus/Marketing, MBA, GAIDC 

Philip is Vice President and General Manager of the Spectroscopy and Vacuum Solutions Division within Agilent’s Life Science and Applied Markets Group, incorporating centres of excellence in Research & Development, Marketing and Manufacturing in Australia, Japan, Italy, UK and the USA.

Philip joined the Spectroscopy Division of Varian, Inc. in 1994, after beginning his career in the mining and minerals industry.  He has held management positions in product marketing, development, and sales and operations.  In 2004 Philip was appointed Managing Director of Varian Australia and General Manager of Varian’s Asia Pacific operations.  In 2010 with the acquisition of Varian by Agilent Technologies, Philip was appointed to the role of Vice President and General Manager of the company’s global Spectroscopy Solutions Division. 

In 2008 Philip was appointed by the Federal government to chair the Future Industry Innovation Council and in 2012 served on the Prime Minister’s Manufacturing Task Force. He is currently a member of the Victorian state government’s Advanced Manufacturing Advisory Council, Chairman of Bionic Enterprises, and is a National Councillor for the Australian Industry Group.

Professor Field Rickards

BSc, MEd(Manc), PhD 

Field Rickards was appointed Dean of the Faculty of Education at the University of Melbourne in August 2004.  Prior to this appointment he was President of the Academic Board and Pro Vice-Chancellor. He joined the Faculty of Education in 1989 from the Department of Otolaryngology in the Faculty of Medicine, having been first appointed to the University of Melbourne as lecturer in 1973 to lead Australia’s first post-graduate training in audiology in 1974. He was appointed to Professor of Education of the Hearing-Impaired in 1994. From 1994 to 2000 he served as Head of Department. He has been a member of various Faculty, Academic Board, University and University Council Committees and was Deputy Dean of the School of Graduate studies (1999-2001). He concluded 13 years as Dean in July 2017, and continues at the University of Melbourne as Dean Emeritus.

He is currently a member of the Hearing CRC Ltd Board.  He concluded his terms as Director of the Royal Children’s Hospital Education Institute and Chair of the Asia Education Advisory Board in 2017.

Ms Christina Hardy

BBus-Comm, LLB, Grad Dip (Mgmt), GAICD

Christina heads Corporate Development and Legal at Genome.One, Sydney, a health information and pathology company established with the strategic objective of using genomic information to inform clinical and health management decision making.  Genome.One was established by the Garvan Institute of Medical Research in 2016 where Christina led technology commercialisation and business affairs for several years.

Christina’s background includes corporate and commercial law (in-house counsel and in private practice) in Australia, the UK and Asia principally in the ICT sector.  Earlier in her career she spent several years working in politics and in public relations. Commercialising and translating technology into healthcare is a key focus area.

 Board_RogerGillepsie.JPG

 Mr Roger Gillespie OAM

Roger Gillespie OAM is co-founder and Executive Chairman of Baker’s Delight, the largest national chain of bakeries in Australia with over 700 bakeries operating throughout Australia, New Zealand and Canada. He has been inducted into the Hall of Fame for both the Swinburne University of Technology’s Australian Graduate School of Entrepreneurship (AGSE) and the Franchising Council of Australia. Roger has been named ‘Citizen of the Year’ for the City of Boroondara and was granted an Order of Australia for his tireless work within the community. 

Roger is a Board Member of the Bionics Institute’s subsidiary Bionic Enterprises. He is also a Board member of the Cranlana Programme, an educational entity geared at leadership development; Director of Epic Health, a small integrated health care business; Director of NQR, a supermarket chain; and President of the Australian Retailers’ Association.

Ms Moya Mills

BA

Moya has many years of experience in the areas of values-based leadership education, ethics education and cross-sector initiatives between the private, public and not-for-profit sectors.  Moya was the Inaugural Executive Director of The Cranlana Programme, having developed that initiative of The Myer Foundation from inception.

Moya has qualifications in the social sciences and management together with a broad background working in the not-for-profit sector.


 Kathleen Jordan_204.jpg

 

Ms Kathleen Jordan

BA (Psych) FAICD

Kathleen brings over 20 years’ experience in organisational change, leadership development and executive coaching across all sectors, nationally and internationally.  She is the Principal Consultant with iNTUITIVE iNSIGHTS and has been the Managing Director of KJ Enterprising Solutions P/L for 15 years.

Kathleen is a Fellow of the Australian Institute of Company Directors.

Kathleen took leave of absence from the Board in 2011 for health reasons and was welcomed back in 2017.

Dr Stella Clark

PhD (Melb), GAICD

After gaining a PhD in 1984, Stella Clark had a distinguished career in diabetes research before moving into research management. Stella has served as: CEO of the Bio21 Cluster, Victoria’s leading health sciences/biotechnology cluster; CEO of Obesity Australia; General Manager, School of Graduate Studies, University of Melbourne; and Scientific Executive Officer, Baker Medical Research Institute.

She has been President of the Australian Society for Medical Research, Australasian Research Management Society; a Member of NHMRC Council; a Member of NHMRC Council; a Member of the Leadership Victoria Board; and a Director of the BioMelbourne Network.

Stella currently runs her own consulting business, Stella Connect P/L, is a Trustee of the Queen Victoria Women’s Centre, co-Chairs the Hugh Rogers Fellowships Committee of the Melbourne Boston Sister City Association and is Chair of the Victorian Cancer Biobank Board.

 

Board_CharlesBagot.jpg

 

Mr Charles Bagot

LLB (Hons)

Charles Bagot is a commercial lawyer. He was a partner of Piper Alderman Lawyers and served in a number of leadership roles including as the firm’s Chair and Head of its Corporate Division. He is experienced in the fields of mergers, acquisitions and privatisations as well as corporate governance. He also had interests in the commercialisation of intellectual property and in resolving company and board disputes. He remains a consultant to Piper Alderman.

Charles was a member of the Council of the University of Adelaide and Chair of its Finance Committee. He is a Director of investment company Kalymna Pty Ltd. Charles formerly served as a Director of the Australian Submarine Company, and of the Australian Institute of Company Directors. He was also Chair of the Ingleby Australia Trust, an agribusiness investor.

 

Sign In